Targeted inhibition of XPO1 by the selective inhibitor selinexor leads to cancer cell death through accumulation of tumor suppressor proteins in the nucleus, dysregulation of growth regulatory proteins and blockade of oncogene protein translation (21). Here, TCHP is linked to cancer.